Re: Prostate Cancer Mortality and Metastasis under Different Biopsy Frequencies in North American Active Surveillance Cohorts

被引:0
|
作者
Taneja, Samir S.
机构
来源
JOURNAL OF UROLOGY | 2020年 / 204卷 / 02期
关键词
D O I
10.1097/JU.0000000000001115.01
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:387 / 387
页数:1
相关论文
共 50 条
  • [1] Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts
    Lange, Jane M.
    Laviana, Aaron A.
    Penson, David F.
    Lin, Daniel W.
    Bill-Axelson, Anna
    Carlsson, Sigrid, V
    Newcomb, Lisa F.
    Trock, Bruce J.
    Carter, H. Ballentine
    Carroll, Peter R.
    Cooperberg, Mathew R.
    Cowan, Janet E.
    Klotz, Laurence H.
    Etzioni, Ruth B.
    CANCER, 2020, 126 (03) : 583 - 592
  • [2] PROSTATE CANCER MORTALITY AND METASTASIS UNDER DIFFERENT BIOPSY FREQUENCIES IN NORTH AMERICAN ACTIVE SURVEILLANCE COHORTS
    Lange, Jane
    Etzioni, Ruth
    MEDICAL DECISION MAKING, 2020, 40 (01) : E302 - E303
  • [3] Re: Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts Editorial Comment
    Resnick, Matthew J.
    JOURNAL OF UROLOGY, 2018, 200 (03): : 488 - 489
  • [4] Re: Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2018, 199 (05): : 1112 - 1113
  • [5] Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts
    Inoue, Lurdes Y. T.
    Lin, Daniel W.
    Newcomb, Lisa F.
    Leonardson, Amy S.
    Ankerst, Donna
    Gulati, Roman
    Carter, H. Ballentine
    Trock, Bruce J.
    Carroll, Peter R.
    Cooperberg, Matthew R.
    Cowan, Janet E.
    Klotz, Laurence H.
    Mamedov, Alexandre
    Penson, David F.
    Etzioni, Ruth
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (01) : 1 - +
  • [6] Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts
    Drost, Frank Jan H.
    Nieboer, Daan
    Morgan, Todd M.
    Carroll, Peter R.
    Roobol, Monique J.
    Trock, Bruce
    Ehdaie, Behfar
    Carroll, Peter
    Filson, Christopher
    Kim, Jeri
    Logothetis, Christopher
    Morgan, Todd
    Klotz, Laurence
    Pickles, Tom
    Hyndman, Eric
    Moore, Caroline M.
    Gnanapragasam, Vincent
    Van Hemelrijck, Mieke
    Dasgupta, Prokar
    Bangma, Chris
    Roobol, Monique
    Villers, Arnauld
    Rannikko, Antti
    Valdagni, Riccardo
    Perry, Antoinette
    Hugosson, Jonas
    Rubio-Briones, Jose
    Bjartell, Anders
    Hefermehl, Lukas
    Shiong, Lee Lui
    Frydenberg, Mark
    Kakehi, Yoshiyuki
    Ha Chung, Byung
    van der Kwast, Theo
    van der Linden, Wim
    Hulsen, Tim
    de Jonge, Cees
    Kattan, Mike
    Ji Xinge
    Muir, Kenneth
    Lophatananon, Artitaya
    Fahey, Michael
    Steyerberg, Ewout
    Zhang, Liying
    Beckmann, Kerri
    Denton, Brian
    Hayen, Andrew
    Boutros, Paul
    Guo, Wei
    Benfante, Nicole
    EUROPEAN UROLOGY, 2019, 76 (05) : 693 - 702
  • [7] Re: Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study
    Denize, Justine
    Nouhaud, Francois-Xavier
    Cornu, Jean-Nicolas
    Pfister, Christian
    JOURNAL OF UROLOGY, 2017, 198 (03): : 709 - 710
  • [8] Re: Understanding Active Surveillance for Prostate Cancer
    Resnick, Matthew J.
    JOURNAL OF UROLOGY, 2022, 207 (06): : 1338 - 1338
  • [9] Re: Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study Reply
    不详
    JOURNAL OF UROLOGY, 2017, 198 (03): : 710 - 711
  • [10] ACTIVE SURVEILLANCE IN PROSTATE CANCER PATIENTS: PREDICTING THE CHANCE OF CONTINUING AS AFTER RE-BIOPSY
    Nicolai, Nicola
    Alvisi, Maria Francesca
    Rancati, Tiziana
    Avuzzi, Barbara
    Badenchini, Fabio
    Catanzaro, Mario
    Colecchia, Maurizio
    Di Florio, Teresa
    Magnani, Tiziana
    Marenghi, Cristina
    Massa, Simona
    Morlino, Sara
    Chiorda, Barbara Noris
    Paolini, Biagio
    Stagni, Silvia
    Tesone, Antonio
    Torelli, Tullio
    Villa, Sergio
    Zaffaroni, Nadia
    Salvioni, Roberto
    Valdagni, Riccardo
    ANTICANCER RESEARCH, 2018, 38 (04) : 2496 - 2498